These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues. Florentin I, Chung V, Martinez J, Maral J, Le Garrec Y, Mathé G. Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822 [Abstract] [Full Text] [Related]
9. Quantitative assessment of tuftsin receptor expression and second messenger during in vitro differentiation of peripheral blood derived monocytes of leprosy patients. Khare S, Bhutani LK, Rao DN. Mol Cell Biochem; 1997 Jun; 171(1-2):1-10. PubMed ID: 9201689 [Abstract] [Full Text] [Related]
10. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs. Semion IZ, Nawrocka E, Słoń J, Tartar A, Obuchowicz E, Gołba K, Herman ZS. Pol J Pharmacol Pharm; 1990 Jun; 42(4):393-401. PubMed ID: 1711198 [Abstract] [Full Text] [Related]
12. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity. Najjar VA, Konopinska D, Chaudhuri MK, Schmidt DE, Linehan L. Mol Cell Biochem; 1981 Dec 04; 41():3-12. PubMed ID: 6895774 [Abstract] [Full Text] [Related]
13. Bactericidal activity of tuftsin. Martinez J, Winternitz F. Mol Cell Biochem; 1981 Dec 04; 41():123-36. PubMed ID: 6799777 [Abstract] [Full Text] [Related]
17. Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro. Spirer Z, Zakuth V, Tzehoval E, Dagan S, Fridkin M, Golander A, Melamed I. J Clin Lab Immunol; 1989 Jan 04; 28(1):27-31. PubMed ID: 2786082 [Abstract] [Full Text] [Related]